Abstract
Alcohol use disorder is one of the major health concerns for veterans, as well as for the general
population. An integral part of the mission of the VA is to provide care for VA patients suffering
from alcohol and/or drug abuse problems with and without comorbid anxiety. The overall aim of
Dr. Pandey’s research program is to elucidate the epigenetic mechanisms that underlie the
pathophysiology of alcohol use disorder (AUD) and co-morbid anxiety disorders. Numerous
studies performed by Dr. Pandey’s laboratory have found that ethanol exposure results in
epigenetic alterations involving histone acetylation/methylation, DNA methylation, and non-
coding RNAs that modulate gene expression in the amygdala. The major focus of his
laboratory is the role of these epigenetic mechanisms and non-coding RNAs in
transcriptomic changes in specific neural circuitries, particularly in the amygdala, and
the subsequent induction of behavioral phenotypes that underlie ethanol withdrawal-
induced anxiety and the co-morbidity of anxiety and AUD. His lab investigates the
differential epigenetic effects of acute and chronic alcohol exposure and withdrawal in both
early-life and adult animal models, as well as in adult animals that were exposed to alcohol in
adolescence. These findings are then translated to humans using postmortem brains of
individuals with AUD and control subjects. In addition to his own laboratory’s research, Dr.
Pandey has programmed several events for the educational enrichment of next-
generation and current researchers in the field and is involved in many collaborative
studies with VA and UIC researchers. Taken together, these research projects are shaping
the field’s understanding of AUD and will inform the development of novel pharmacological
interventions for the treatment of AUD, with and without comorbid anxiety, in veterans and in the
general population.
Public Health Relevance Statement
Project Narrative
Veterans suffering from post-traumatic stress disorder (PTSD) experience high anxiety levels,
which increases their susceptibility to alcohol and drug addiction. As a result, alcohol use
disorder (AUD) is one of the major health concerns for veterans. This research program will
elucidate various epigenetic mechanisms in brain circuitry associated with the development of
alcohol addiction in concert with anxiety-like behaviors. This research will inform the
development of novel pharmacological therapies that target these molecular pathways in order
to treat AUD, both with and without comorbid anxiety.
NIH Spending Category
No NIH Spending Category available.
Project Terms
ATAC-seqAcuteAdolescenceAdolescentAdultAlcohol abuseAlcohol consumptionAlcohol dependenceAlcohol withdrawal syndromeAmygdaloid structureAnimal ModelAnti-Anxiety AgentsAnxietyAnxiety DisordersAreaAutopsyAwardBehaviorBig DataBrainCaringCell physiologyChIP-seqChemicalsChronicClinical ResearchDNADNA MethylationDependenceDevelopmentDrug AddictionDrug DesignDrug abuseEducationEpigenetic ProcessEventFunctional disorderFundingFutureGene ExpressionGeneral PopulationGenesGenomeGrantHealthHealthcareHistone AcetylationHistonesHumanIndividualInterventionLaboratoriesLaboratory ResearchLifeMaintenanceMethylationMissionModificationMolecularNational Institute on Alcohol Abuse and AlcoholismNeurobiologyNeurosciencesPathway interactionsPatient CarePatientsPhysiologyPopulationPost-Traumatic Stress DisordersPostdoctoral FellowPredispositionProcessResearchResearch PersonnelResearch Project GrantsResearch TrainingRisk FactorsRoleScientistSeriesShapesSymptomsSynaptic plasticityTrainingTranslatingTranslationsUnited States National Institutes of HealthUntranslated RNAVeteransWorkadolescent alcohol exposureadolescent binge drinkingalcohol abuse therapyalcohol effectalcohol exposurealcohol researchalcohol use disorderalcohol use initiationanxiety-like behaviorbehavioral phenotypingbrain circuitrycareercomorbiditydrinking behaviorexperienceexperimental studymature animalmolecular targeted therapiesneural circuitnext generationnovelpharmacologicpre-doctoralpreclinical studyprogramssubstance usetherapeutic developmenttranscriptome sequencingtranscriptomicsunderage drinkingwithdrawal-induced anxiety
No Sub Projects information available for 5IK6BX006030-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5IK6BX006030-02
Patents
No Patents information available for 5IK6BX006030-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5IK6BX006030-02
Clinical Studies
No Clinical Studies information available for 5IK6BX006030-02
News and More
Related News Releases
No news release information available for 5IK6BX006030-02
History
No Historical information available for 5IK6BX006030-02
Similar Projects
No Similar Projects information available for 5IK6BX006030-02